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Abstract: The CNS is enriched in phosphoinositide-
specific phospholipase C (PLC) and in the G proteins
linked to its activation. Although the regional distributions
of these signaling components within the brain have been
determined, neither their cell type-specific localizations
(i.e., neuronal versus glial) nor the functional significance
of their high expression has been definitively established.
In this study, we have examined the expression of phos-
phoinositide signaling proteins in human NT2-N cells, a
well characterized model system for CNS neurons. Reti-
noic acid-mediated differentiation of NT2 precursor cells
to the neuronal phenotype resulted in five- to 15-fold
increases in the expression of PLC-b1, PLC-b4, and
Gaq/11 (the prime G protein activator of these isozymes).
In contrast, the expression of PLC-b3 and PLC-g1 was
markedly reduced following neuronal differentiation. Sim-
ilar alterations in cell morphology and in the expression of
PLC-b1, PLC-b3, and Gaq/11 expression were observed
when NT2 cells were differentiated with berberine, a
compound structurally unrelated to retinoic acid. NT2-N
neurons exhibited a significantly higher rate of phospho-
inositide hydrolysis than NT2 precursor cells in response
to direct activation of either G proteins or PLC. These
results indicate that neuronal differentiation of NT2 cells
is associated with dramatic changes in the expression of
proteins of the phosphoinositide signaling system and
that, accordingly, differentiated NT2-N neurons possess
an increased ability to hydrolyze inositol lipids. Key
Words: G proteins, Gq/11, Go—Retinoic acid—Phospho-
lipase C isozymes—Berberine—Inositol phosphates.
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Receptor-stimulated phosphoinositide hydrolysis, with
the attendant formation of the second messengers inosi-
tol 1,4,5-trisphosphate and diacylglycerol, represents a
major signal transduction pathway in the CNS (for re-
view, see Fisher et al., 1992). Agonist occupancy of
phosphoinositide-linked receptors results primarily in the
activation of heterotrimeric guanine nucleotide binding
proteins (G proteins), chief of which is Gq/11 (Simon
et al., 1991; Jope et al., 1994). Gaq/11 is expressed at
relatively high concentrations in highly specialized re-
gions of the CNS, such as frontal cortex, olfactory bulb,
caudate-putamen, hippocampal pyramidal cells, and cer-
ebellar Purkinje cells (Mailleux et al., 1992; Milligan,
1993; Friberg et al., 1998). Gaq/11 is linked preferentially
to the activation of theb1 andb4 isozymes of phospho-
inositide-specific phospholipase C (PLC) (Taylor et al.,
1991; Jiang et al., 1994; Lee et al., 1994), both of which
colocalize with Gaq/11 (Ross et al., 1989; Roustan et al.,
1995). High levels of PLC-b1 expression have been
linked to neuronal differentiation and synaptic plasticity
in the postnatal rat cortex (Hannan et al., 1998). In
contrast, PLC-b3, which is preferentially activated by
Gbg subunits, is expressed only minimally in brain
(Tanaka and Kondo, 1994; Watanabe et al., 1998) at a
level estimated to be 1% of that of PLC-b1 (Jhon et al.,
1994).
Despite the known regional distribution and enrich-
ment of Gaq/11 and PLC isozymes in the brain, a number
of issues remain to be addressed. One is whether the
expression of these phosphoinositide signaling proteins
is homogeneous within a region of the brain or, alterna-
tively, whether these components are enriched in specific
neuronal and/or glial cell populations. Although previous
studies, based on immunohistochemical criteria, have
indicated that the expression of phosphoinositide signal-
ing proteins may be cell type-specific, some of these
reports are inconsistent (e.g., for Gaq/11 localization to
glia versus neurons, see Mailleux et al., 1992 versus
Friberg et al., 1998, respectively) or incomplete (e.g., for
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localization of the PLC-b family but not individual
isozymes, see Mizuguchi et al., 1991). A separate issue is
whether the relative enrichment of Gaq/11 and PLC-b in
neural tissues results in correspondingly higher rates of
phosphoinositide turnover. Such a relationship might in-
dicate that the concentrations of Gaq/11and/or PLC-b are
rate-limiting for inositol lipid hydrolysis.
NT2-N neuronal cells, which are obtained by retinoic
acid treatment of NT2 human teratocarcinoma precursors
and comprise a relatively pure population of postmitotic
CNS neurons (Andrews, 1984; Pleasure et al., 1992),
offer an ideal cell culture model with which to address
these issues. NT2-N neurons aggregate into highly po-
larized ganglia with morphologically identifiable axons
and dendrites; they express numerous CNS neuron-spe-
cific proteins, such as neurofilaments (Lee and Andrews,
1986), neural cell adhesion molecules (Pleasure et al.,
1992), NMDA receptors (Younkin et al., 1993), and
tyrosine hydroxylase (Iacovitti and Stull, 1997), and they
form functional synapses (Sheridan and Maltese, 1998;
Hartley et al., 1999). These cells do not, however, ex-
press glial or PNS neuronal markers (Lee and Andrews,
1986; Pleasure et al., 1992). We have recently shown that
differentiation of NT2 cells to the neuronal phenotype is
associated with an;10-fold increase inmyo-inositol
content, a result that is consistent with the known high
concentration of this polyol in brain (Novak et al.,
1999b). However, phosphoinositide signaling has not
previously been systematically investigated in NT2-N
neurons. We now report that differentiation of NT2 stem
cells to the neuronal phenotype results in dramatic
changes in the expression of phosphoinositide signaling
proteins. Specifically, the concentrations of Gaq/11, PLC-
b1, and PLC-b4 are markedly increased (five- to 15-
fold), whereas that of PLC-b3 is greatly reduced. Fur-
thermore, the enhanced expression of Gaq/11, PLC-b1,
and PLC-b4 observed for NT2-N neurons is accompa-
nied by substantial increases in the rate of phosphoino-
sitide hydrolysis in response to direct activation of either
G proteins or PLC. A preliminary account of part of this
study has been reported previously (Novak et al., 1999a).
MATERIALS AND METHODS
Materials
myo-[3H]Inositol (80 Ci/mmol), enhanced chemilumines-
cence reagents, high-range molecular weight rainbow markers,
and peroxidase-conjugated sheep anti-mouse IgG were ob-
tained from Amersham (Arlington Heights, IL, U.S.A.). Mono-
clonal antibody to PLC-g1 was from Upstate Biotechnology
(Lake Placid, NY, U.S.A.). Peroxidase-conjugated goat anti-
rabbit IgG and polyclonal antibodies to PLC-b1, PLC-b2,
PLC-b3, PLC-b4, Gaq/11, Gai, Gao, and Gas were supplied by
Santa Cruz Biotechnology (Santa Cruz, CA, U.S.A.). Immo-
bilon-P polyvinylidene difluoride (PVDF) membranes were
obtained from Millipore (Bedford, MA, U.S.A.). Alltrans-
retinoic acid, berberine chloride,N6,29-O-dibutyryladenosine
39,59-cyclic monophosphate [dibutyryl cyclic AMP (db-
cAMP)], and digitonin were purchased from Sigma Chemical
(St. Louis, MO, U.S.A.). Ionomycin and guanosine 59-O-(3-
thiotriphosphate) tetralithium salt (GTPgS) were from Calbio-
chem (La Jolla, CA, U.S.A.). Cell culture reagents and supplies
were obtained as described previously (Novak et al., 1999b)
except fetal calf serum, which was supplied by Summit Bio-
technology (Fort Collins, CO, U.S.A.). Bicinchoninic acid pro-
tein assay reagents were obtained from Pierce (Rockford, IL,
U.S.A.). UniverSol-ES liquid scintillation cocktail was from
ICN (Costa Mesa, CA, U.S.A.). Dowex AG 1-X8 resin (100–
200 mesh; formate) was purchased from Bio-Rad Laboratories
(Hercules, CA, U.S.A.). C6 glioma cells were a gift from Dr.
William Mancini (University of Michigan), originally obtained
from the American Type Culture Collection. Forebrain samples
from 50-day-old male Sprague–Dawley rats (220–250 g) were
a gift from Dr. Kirk Frey (University of Michigan).
Cell culture
NT2 stem cells were cultured and induced to differentiate to
NT2-N neurons by means of treatment with retinoic acid (5
weeks) and mitotic inhibitors (3 weeks) as previously described
(Novak et al., 1999b). In some experiments, partial differenti-
ation of NT2 cells was achieved by maintenance (72 h) in
medium supplemented with either 10mM retinoic acid, 10
mg/ml berberine, or 100mM db-cAMP followed by mainte-
nance (72 h) in medium alone. Human SH-SY5Y neuroblas-
toma and rat C6 glioma cells were maintained in Dulbecco’s
modified Eagle’s medium supplemented with 10% (vol/vol)
fetal calf serum at 37°C and passaged once each week by
incubation with buffer containing 0.05% (wt/vol) trypsin and
0.53 mM EDTA.
Sodium dodecyl sulfate–polyacrylamide gel
electrophoresis (SDS-PAGE)
NT2 or NT2-N cells, adherent to 6-cm dishes, were rinsed
with ;3 ml of ice-cold buffer A (142 mM NaCl, 5.6 mM KCl,
2.2 mM CaCl2, 3.6 mM NaHCO3, 1 mM MgCl2, 30 mM
HEPES, and 5.6 mM D-glucose, pH 7.4) and incubated on ice
with 300–500ml of lysis buffer [50 mM NaCl, 20 mM HEPES,
1 mM EGTA, 1% (vol/vol) Triton X-100, 30 mM sodium
pyrophosphate, 5 mM b-glycerophosphate, 1 mM phenylmeth-
ylsulfonyl fluoride, 10mg/ml aprotinin, and 10mg/ml leupep-
tin, pH 7.4 (Wahl et al., 1988)]. Cell lysates were scraped into
microcentrifuge tubes on ice and centrifuged at 7,800g for 2
min to remove debris. Supernatants (25mg) were boiled in
sample buffer [200 mM Tris (pH 6.7), 5% (wt/vol) SDS, 20%
(vol/vol) glycerol, 1M b-mercaptoethanol, and 0.1% (wt/vol)
bromphenol blue] for 5 min and electrophoresed through 10%
polyacrylamide gels (Laemmli, 1970). Proteins were then
transferred to PVDF membranes for immunoblot analysis.
Immunoblot analysis
Membranes were treated with phosphate-buffered saline
(138 mM NaCl, 8.1 mM Na2HPO4, 2.7 mM KCl, and 1.2 mM
KH2PO4, pH 7.4) supplemented with 0.1% (vol/vol) Tween 20
(PBS-Tw), 1% (wt/vol) bovine serum albumin, and 0.01%
(wt/vol) NaN3 for 1 h to block nonspecific binding sites.
Primary antibodies were diluted in blocking solution (0.1–0.5
mg/ml final concentration) and incubated with membranes for
1 h, which were then washed three times with PBS-Tw to
remove excess antibody. Secondary antibodies were diluted in
PBS-Tw (1:10,000) and incubated with membranes for 1 h,
which were again washed three times with PBS-Tw. Immuno-
reactive proteins were detected by enhanced chemilumines-
cence. In some experiments, membranes were subsequently
incubated in stripping solution [0.1M Tris (pH 8.0), 2% (wt/
vol) SDS, and 100 mM b-mercaptoethanol] for 30 min at 52°C,
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washed twice with PBS-Tw, and reprobed with a different
primary antibody as described above. Quantitative analysis of
autoluminograms was performed by computer-assisted imaging
densitometry (MCID; Imaging Research, St. Catharines, On-
tario, Canada).
Measurement of phosphoinositide hydrolysis
Intact cells.NT2 stem cells and NT2-N neurons were pre-
labeled for 48–72 h at 37°C in medium supplemented with
10–20mCi/ml [3H]inositol, by which time labeling of inositol
lipids had achieved isotopic equilibrium (Novak et al., 1999b).
Cells adherent to 6-cm dishes were rinsed with 2 ml of buffer
A and incubated for 15 min at 37°C in 1.5 ml of the same buffer
that contained 30 mM LiCl with or without 20 mM NaF or 1
mM ionomycin. Reactions were terminated by the rapid aspi-
ration of buffer and the addition of 23 1 ml of 6% (wt/vol)
ice-cold trichloroacetic acid. Cell lysates were scraped into
centrifuge tubes on ice and centrifuged at 2,400g for 5 min at
4°C. The supernatants were washed with 53 2 ml of water-
saturated diethyl ether and neutralized with NaHCO3. Radio-
activity associated with3H-inositol phosphates in the superna-
tants was quantified as previously described (Fisher et al.,
1984). The cell pellets were analyzed to determine the incor-
poration of [3H]inositol into phosphoinositides as described
(Novak et al., 1999b). Production of inositol phosphates was
then normalized as the ratio of3H-inositol phosphates to total
radioactivity (i.e., that present in inositol phosphates and ino-
sitol phospholipids).
Permeabilized cells.NT2 and NT2-N cells were prelabeled
as above, rinsed with 2 ml of KGEH buffer (139 mM potassium
glutamate, 10 mM EGTA, 30 mM HEPES, 10 mM LiCl, 4 mM
MgCl2, and 2 mM ATP, pH 7.4), and incubated for 5 min at
37°C in 2 ml of the same buffer supplemented with 20mM
digitonin. Permeabilized cells were then rinsed with 2 ml of
KGEH buffer and incubated for 60 min in 1.5 ml of the same
buffer that contained various concentrations of Ca21 with or
without 50 mM GTPgS. Required free Ca21 concentrations
were achieved by the addition of various amounts of CaCl2 to
the KGEH buffer that contained 10 mM EGTA as previously
described (Fisher et al., 1989). Reactions were terminated by
the removal of the buffer to centrifuge tubes on ice and the
addition of 23 0.5 ml of 6% (wt/vol) ice-cold trichloroacetic
acid to the permeabilized cells. Cell lysates were scraped into
the same centrifuge tubes and centrifuged at 2,400g for 5 min
at 4°C. Release of3H-inositol phosphates was then quantified
as described above.
Data analysis
Results shown represent mean6 SEM values for the num-
ber (n) of independent experiments performed. Duplicate or
triplicate values were obtained for each parameter measured.
Student’s two-tailedt tests were used to evaluate the statistical
differences between the means of paired or unpaired sets of
data.
RESULTS
Neuronal differentiation of NT2 cells results in
selective changes in the expression of G proteins
and PLC isozymes
To assess the effect of neuronal differentiation on
signal transduction proteins, the expression of various G
proteins in NT2 stem cells and 9-week-old, retinoic
acid-induced NT2-N cells was determined by immuno-
blot (Fig. 1). The immunoreactivity of Gaq/11, which is
the prime activator of PLC-b1 and PLC-b4 (Taylor
et al., 1991; Jiang et al., 1994), was markedly increased
in NT2-N neurons (1,4706 320% of that in NT2 cells,
n 5 11, p , 0.0001). The expression of the neuron-
enriched G protein Gao (Strittmatter et al., 1990) was
also increased following the appearance of the neuronal
phenotype (2,8606 460% of that of NT2 cells, n5 4, p
, 0.05). In contrast, only small increases in the expres-
sion of Gai and Gas were observed following differen-
tiation (1806 10% and 2806 50% of that present in
NT2 cells, respectively, n5 5–6, p , 0.05). The ex-
pression of PLC isozymes following neuronal differen-
tiation was also measured (Fig. 2). Immunoreactivity
associated with PLC-b1 in NT2-N neurons increased to
1,2606 360% of that present in NT2 precursors (n5 11,
p , 0.001). PLC-b4 expression in NT2-N neurons was
also elevated with respect to that in NT2 cells (560
6 170%, n5 3, p , 0.05). These two PLC isozymes are
also enriched in specific regions of the CNS (Watanabe
et al., 1998). In contrast, the immunoreactivity of
FIG. 1. G protein expression in NT2 precursors and NT2-N
neurons. Cell lysates were centrifuged, and duplicate aliquots of
supernatant (25 mg) were subjected to SDS-PAGE, transferred to
PVDF membranes, and immunoblotted for Gaq/11, Gai, Gao, or
Gas as described in Materials and Methods. Blots are represen-
tative of 11, five, four, and six independent experiments, respec-
tively.
FIG. 2. PLC expression in NT2 precursors and NT2-N neurons.
Cell lysates were centrifuged, and duplicate aliquots of super-
natant (25 mg) were subjected to SDS-PAGE, transferred to
PVDF membranes, and immunoblotted for PLC-b1, PLC-b3,
PLC-b4, or PLC-g1 as described in Materials and Methods.
Blots are representative of 11, 12, three, and four independent
experiments, respectively.
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PLC-b3 was relatively low in NT2-N neurons (186 4%
of that in NT2 cells, n5 12, p , 0.001), as was that of
PLC-g1 (36 6 6%, n 5 4, p , 0.05). PLC-b2 immu-
noreactivity was not detected in either NT2 or NT2-N
cells (data not shown).
Both retinoic acid and berberine treatment of NT2
cells results in a neuronal phenotype and altered
expression of phosphoinositide signaling proteins
Although the acquisition of neuronal morphological
characteristics following retinoic acid treatment of NT2
cells is well established (Andrews, 1984; Pleasure et al.,
1992), we nonetheless wished to determine whether the
observed changes in the expression of phosphoinositide
signaling proteins were specific to the use of retinoic acid
alone. To evaluate this possibility, differentiation of NT2
cells to the neuronal phenotype was promoted by means
of treatment with either 10mM all trans-retinoic acid or
10 mg/ml berberine (Fig. 3), a structurally unrelated
alkaloid (Chang, 1991). In addition, some cells were
treated with 100mM db-cAMP, which has been reported
to induce differentiation of these cells to a nonneuronal
phenotype (Andrews et al., 1986). For these experiments,
incubation with differentiating agents was limited to
72 h, because prolonged treatment with berberine re-
duced cell viability. Before differentiation, NT2 precur-
sors appeared amorphous and proliferated rapidly (Fig.
4A). NT2 cells incubated with either retinoic acid or
berberine, however, ceased to divide and demonstrated a
dramatically altered morphology, such as cell polariza-
tion and the elaboration of neurites (Fig. 4B and C,
respectively). These properties were also observed for
fully differentiated NT2-N neurons (Fig. 4E). In contrast,
cells incubated with db-cAMP did not acquire this neu-
ronal morphology, but became larger and epithelioid
(Fig. 4D).
Neuronal alterations in morphology were accompa-
nied by specific changes in the expression of G proteins
and PLC isozymes (Figs. 5 and 6). The expression of
Gaq/11, which was strongly up-regulated following com-
plete (9-week) differentiation to NT2-N neurons (see
Fig. 1), rose to;300% of that present in NT2 cells
following a 72-h treatment with either retinoic acid or
berberine. In contrast, differentiation of NT2 stem cells
to an epithelioid phenotype had no effect on the Gaq/11
immunoreactivity (Fig. 5, top). Similarly, expression of
PLC-b1 increased significantly following either retinoic
acid or berberine treatment, but was unchanged by ex-
posure of NT2 cells to db-cAMP (Fig. 6, top). Gai,
whose concentration in NT2-N neurons was only slightly
higher than that in NT2 stem cells, remained relatively
constant with all three treatments (Fig. 5, bottom). Con-
versely, the immunoreactivity of PLC-b3, which de-
clines following 9 weeks of neuronal differentiation (see
Fig. 2), also decreased by 60–80% during a 72-h expo-
sure to either retinoic acid or berberine, whereas PLC-b3
expression was unchanged following treatment with db-
cAMP (Fig. 6, bottom).
Expression of G proteins and PLC isozymes in
NT2-N neurons approximates that observed
for brain
It is not yet established how individual cell popula-
tions within the brain contribute to the overall expression
of G proteins and PLC isozymes. To address this ques-
tion, concentrations of G proteins and PLC isozymes in
NT2-N neurons were compared with those in rat C6
glioma cells (a glial cell model), human SH-SY5Y neu-
roblastoma cells (a PNS neuronal cell model), and rat
forebrain (Figs. 7 and 8). The immunoreactivity of
Gaq/11 in NT2-N neurons was comparable to that ob-
served for forebrain, whereas Gaq/11 expression was
significantly lower in C6 glioma and SH-SY5Y neuro-
blastoma cells (Fig. 7, top). In addition, Gao, which was
undetectable in either C6 or SH-SY5Y cells, was readily
detectable in NT2-N neurons and prominent in whole
brain (Fig. 7, bottom). These data imply that the Gaq/11
and Gao in brain are present at higher concentrations in
neurons than in glia, and that these same G proteins are
expressed more robustly in neurons of the CNS (NT2-N)
than in those of the PNS (SH-SY5Y). The lack of de-
tectable Gao in C6 glioma cells may indicate that this G
protein is specific to neurons in the brain, as has been
suggested (Gierschik et al., 1986); alternatively, the ex-
pression of Gao may vary among glial cell models of
different lineages. Although PLC-b1 was enriched in
NT2-N neurons with respect to SH-SY5Y cells, the
highest concentration of this isozyme was observed for
C6 cells and forebrain, a result that suggests both glial
and neuronal contributions to the PLC-b1 content of
brain (Fig. 8, top). As previously described, the expres-
FIG. 3. Chemical structures of all trans-retinoic acid (A) and
berberine (B).
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sion of PLC-b3 was low in NT2-N neurons (see Fig. 2),
as is observed for whole brain (Watanabe et al., 1998),
whereas relatively high expression of this isozyme was
observed for C6 and SH-SY5Y cells (Fig. 8, bottom).
The high expression of PLC-b3 in C6 cells is at odds
with the relative lack of this isozyme in rat forebrain, a
brain region in which glia far outnumber neurons. One
explanation for this discrepancy might be that the glial
population represented by C6 cells is comparatively rare
or, alternatively, that these cells are reflective of glia in
hindbrain, a region in which PLC-b3 expression is rel-
atively higher than in forebrain (Tanaka and Kondo,
1994; Watanabe et al., 1998).
Increased expression of Gaq/11, PLC-b1, and PLC-
b4 is associated with increased rates of
phosphoinositide hydrolysis
To determine whether the increased expression of
Gaq/11, PLC-b1, and PLC-b4 was accompanied by an
increased rate of inositol lipid hydrolysis,3H-inositol
phosphate production was determined for NT2 stem cells
and NT2-N neurons following either direct G protein or
PLC activation (Fig. 9). Compared to NT2 precursors,
NT2-N neurons exhibited an equivalent incorporation of
[3H]inositol into lipid with respect to protein (data not
shown). In addition, radioactivity was recovered primar-
ily in phosphatidylinositol (96%), with the remainder of
the radioactivity present in phosphatidylinositol 4-phos-
phate and phosphatidylinositol 4,5-bisphosphate in both
cell types. Activation of phosphoinositide hydrolysis at
the level of Gaq/11 following incubation with 20 mM
NaF (Fisher et al., 1993) resulted in a fivefold higher
release of inositol phosphates in NT2-N neurons com-
pared with NT2 stem cells (Fig. 9A). Similarly, direct
stimulation of PLC by treatment with the Ca21 iono-
phore ionomycin (Fisher et al., 1989) produced a four-
fold greater increase in inositol phosphate generation in
FIG. 4. Morphological evidence of neuronal differentiation of NT2 cells following treatment with either retinoic acid or berberine.
Phase-contrast photomicrographs show the following: untreated NT2 precursors (A); NT2 cells incubated with either 10 mM retinoic acid
(B), 10 mg/ml berberine (C), or 100 mM db-cAMP (D) for 72 h as described in Materials and Methods; and 9-week-old, retinoic
acid-induced NT2-N neurons (E). Bar 5 160 mm.
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NT2-N neurons than that observed for NT2 precursors.
Inositol phosphate production in NT2 and NT2-N cells
was also examined with a permeabilized cell paradigm
(Fig. 9B). Incubation with 1–10mM free Ca21 to stim-
ulate PLC directly did not result in significant stimula-
tion of inositol phosphate release from either NT2 or
NT2-N cells. In contrast, the addition of GTPgS to
permeabilized NT2-N neurons resulted in an approxi-
mately fourfold greater increase in inositol phosphate
FIG. 5. G protein expression in retinoic acid-, berberine-, or
db-cAMP-treated NT2 cells. NT2 precursors were incubated
with either 10 mM retinoic acid (RA), 10 mg/ml berberine (B), or
100 mM db-cAMP (cAMP) as described, and duplicate aliquots
of cell lysate supernatant (25 mg) were subjected to SDS-PAGE,
transferred to PVDF membranes, and immunoblotted for Gaq/11
(top) or Gai (bottom). NT2 and NT2-N cell lysates were included
for comparison. Densitometric analyses of G protein expression
relative to NT2 cells are presented as means 6 SEM for three to
five independent experiments. *p , 0.05, **p , 0.01, different
from NT2 cells.
FIG. 6. PLC isozyme expression in retinoic acid-, berberine-, or
db-cAMP-treated NT2 cells. NT2 precursors were incubated
with either 10 mM retinoic acid (RA), 10 mg/ml berberine (B), or
100 mM db-cAMP (cAMP) as described, and duplicate aliquots
of cell lysate supernatant (25 mg) were subjected to SDS-PAGE,
transferred to PVDF membranes, and immunoblotted for
PLC-b1 (top) or PLC-b3 (bottom). NT2 and NT2-N cell lysates
were included for comparison. Densitometric analyses of PLC
isozyme expression relative to NT2 cells are presented as means
6 SEM for four to seven independent experiments. *p , 0.05,
**p , 0.01, different from NT2 cells.
FIG. 7. G protein expression in C6 glioma cells, SH-SY5Y neu-
roblastoma cells, NT2-N neurons, or rat forebrain. Cell lysates
from either C6, SH-SY5Y (SY5Y), or NT2-N cells or tissue lysate
from rat forebrain (RFB) were centrifuged, and duplicate aliquots
of supernatant (25 mg) were subjected to SDS-PAGE, transferred
to PVDF membranes, and immunoblotted for Gaq/11 (top) or Gao
(bottom). Densitometric analyses of G protein expression rela-
tive to NT2-N cells are presented as means 6 SEM for four
independent experiments, with the exception of Gao expression
in C6 and SH-SY5Y cells, in which no immunoreactive bands
were detected. *p , 0.05, **p , 0.01, different from NT2-N
neurons.
FIG. 8. PLC isozyme expression in C6 glioma cells, SH-SY5Y
neuroblastoma cells, NT2-N neurons, or rat forebrain. Cell ly-
sates from either C6, SH-SY5Y (SY5Y), or NT2-N cells or tissue
lysate from rat forebrain (RFB) were centrifuged, and duplicate
aliquots of supernatant (25 mg) were subjected to SDS-PAGE,
transferred to PVDF membranes, and immunoblotted for
PLC-b1 (top) or PLC-b3 (bottom). Densitometric analyses of
PLC isozyme expression relative to NT2-N cells are presented as
means 6 SEM for three to five independent experiments. *p
, 0.05, **p , 0.01, different from NT2-N neurons.
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release than that observed for NT2 cells. Consequently,
direct activation of G proteins in both intact and perme-
abilized cells robustly stimulated inositol phosphate pro-
duction in NT2-N neurons compared to NT2 stem cells.
DISCUSSION
In this report, we demonstrate that the differentiation
of human NT2 cells to the neuronal phenotype is accom-
panied by neuron-specific increases in the expression of
Gaq/11 and of PLC-b1/4. The expression of Gaq/11 in-
creased;15-fold following CNS neuronal differentia-
tion to a concentration similar to that found in rat brain
(;0.1% of membrane protein; Milligan, 1993). Compar-
ison of G protein expression in NT2-N cells relative to
other neural tissues suggests that Gq/11 in brain may be
more highly expressed in neurons than in glia, particu-
larly in neurons of the CNS rather than in those of the
PNS. PLC-b1 and PLC-b4, each of which is activated by
and colocalized with Gaq/11 (Taylor et al., 1991; Jiang
et al., 1994; Jope et al., 1994), were also enriched upon
differentiation to NT2-N neurons, although the high ex-
pression of PLC-b1 in C6 cells implies both neuronal
and glial contributions to the content of this isozyme in
brain. As PLC-b1 and PLC-b4 have been localized to
different regions of the CNS (Watanabe et al., 1998), the
presence of both isozymes at relatively high concentra-
tions in the NT2-N preparation suggests that it may
constitute a mixed cell population. Alternatively, the
NT2-N neuron may represent a fetal stage of CNS neu-
ronal development, as previously indicated (Pleasure
et al., 1992), in which the cell has yet to commit to the
expression of a specific PLC-b isozyme.
The observed increases in Gaq/11, PLC-b1, and
PLC-b4 expression with neuronal differentiation of NT2
cells were specific for these isoforms, because the ex-
pression of both PLC-b3 and PLC-g1 decreased with
differentiation. The latter data are consistent with the low
concentration of these isozymes reported for brain
(Tanaka and Kondo, 1994; Watanabe et al., 1998) and
the probable astroglial localization of PLC-g1 (Choi
et al., 1989). It is noteworthy that the expression of Gai,
which can activate PLC-b3 via the release of Gbg sub-
units, was minimally influenced by neuronal differenti-
ation (see Fig. 1). This observation, along with the pro-
nounced reduction in the expression of PLC-b3 during
differentiation, suggests that in NT2-N neurons, the pre-
dominant mechanism for activation of PLC-b is via
Gaq/11. The robust and specific increases in PLC-b1 and
PLC-b4 expression that were observed in the present
study following neuronal differentiation of NT2 cells are
in marked contrast to the results obtained in a previous
report in which no increased expression of PLC-b1 was
detected (Wolf et al., 1995). Although an explanation for
this discrepancy is not immediately apparent, it should be
noted that we observed similar changes in Gaq/11, PLC-
b1, and PLC-b3 expression regardless of whether neu-
ronal differentiation of NT2 precursors was induced by
retinoic acid or by berberine, a structurally distinct dif-
ferentiating agent. In contrast, when NT2 cells were
treated with db-cAMP, they acquired an epithelioid phe-
notype and showed no change in phosphoinositide sig-
naling protein expression. Collectively, these results in-
dicate that (a) the appearance of the neuronal phenotype
is accompanied by marked changes in the expression of
phosphoinositide signaling proteins and (b) the biochem-
ical changes observed appear to be independent of the
agent used to induce differentiation.
The expression of Gao, a signal transduction protein
not directly involved in phosphoinositide hydrolysis, was
also altered in a manner consistent with neuronal differ-
entiation, because its concentration in NT2-N neurons
was;30 times higher than in NT2 stem cells. Gao has
been estimated to comprise 1–2% of the total membrane
protein of brain (Sternweis and Robishaw, 1984; Gier-
schik et al., 1986) and 10% of the membrane protein of
brain growth cones (Strittmatter et al., 1990). In addition,
increased expression of Gao parallels neurite prolifera-
tion during neuronal differentiation of PC12 cells (Zubi-
aur and Neer, 1993; Strittmatter et al., 1994). Although
the Gao content of NT2-N neurons was much less than
that of whole brain, possibly because NT2-N cells rep-
resent an immature neuronal phenotype and require the
presence of glia for further maturation (Hartley et al.,
1999), it is noteworthy that no Gao was detected in either
C6 glioma or SH-SY5Y neuroblastoma cells, a result that
further strengthens the association of this G protein with
CNS neuronal differentiation.
FIG. 9. Inositol phosphate production by NT2 precursors and
NT2-N neurons. Cells were prelabeled with 10–20 mCi/ml [3H]-
inositol for 48–72 h. Intact cells (A) were incubated in the pres-
ence or absence of either 20 mM NaF or 1 mM ionomycin at 37°C
for 15 min. Permeabilized cells (B) were incubated in the pres-
ence or absence of either 50 mM GTPgS or 1 mM Ca21 at 37°C
for 60 min. Inositol phosphates were quantified as described in
Materials and Methods and expressed as the difference be-
tween the means of experimental and control replicates. Data
shown are means 6 SEM for three to six independent experi-
ments. *p , 0.05, **p , 0.01, ***p , 0.001, different from NT2
cells.
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Although the concentrations of phosphoinositide sig-
naling proteins such as Gaq/11 and PLC-b1/4 are report-
edly high in the CNS (Milligan, 1993; Watanabe et al.,
1998), the relationship between this enhanced protein
expression and the rate of phosphoinositide turnover in
discrete cell populations remains to be determined. In the
present study, we observed that direct activation of
Gaq/11 in either intact or permeabilized NT2-N neurons
resulted in a significantly greater stimulation of phospho-
inositide hydrolysis than in NT2 precursors. Similarly,
direct stimulation of PLC with the Ca21 ionophore iono-
mycin also resulted in a greater increase in inositol lipid
turnover in intact NT2-N neurons than in NT2 stem cells.
These findings are consistent with the possibility that the
increased expression of Gaq/11 and/or PLC-b1/4 results
in a greater ability of neuronal cells to hydrolyze inositol
lipids. A corollary of this conclusion would be that the
concentrations of Gaq/11 and/or PLC-b1/4 are rate-lim-
iting for inositol lipid hydrolysis. In the absence of G
protein stimulation, the basal release of inositol phos-
phates was higher from NT2-N neurons than from NT2
stem cells (data not shown), a finding that suggests that
PLC activity may limit the rate of phosphoinositide hy-
drolysis. This situation would be analogous to that ob-
served for the cyclic AMP signaling system, in which the
activity of the effector enzyme adenylyl cyclase, rather
than the availability of G protein, is rate-limiting for
second messenger production (Alousi et al., 1991; Post
et al., 1995). In the present study, the increased ability of
neurons to hydrolyze inositol lipids does not appear to be
due to differences in the concentrations of inositol lipid
substrates initially present, because lipids in both cell
types were labeled with [3H]inositol to an equivalent
extent. However, the possibility of compartmentation of
phosphoinositide pools within NT2 or NT2-N cells can-
not be excluded.
We conclude that the neuronal differentiation of NT2
cells is accompanied by neuron-specific changes in the
expression of phosphoinositide signaling components as
well as stimulated hydrolysis of inositol lipids. The
NT2-N cell system may thus serve as a useful and
representative model with which to further investigate
phosphoinositide signaling in human CNS neurons.
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